Table 3.
Incidence rates of ocular complications and best-corrected visual acuity loss for eyes of patients diagnosed with ocular syphilisa (n = 204 total eyes for which there was follow-up, 110 HIV-negative eyes and 59 HIV-positive eyes).
| Variable | All eyes | HIV-negative eyes | HIV-positive eyes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number at risk | Number of events | Incidence rate (per eye-year) | Poisson Exact CI 95% | Number at risk | Number of events | Incidence rate (per eye-year) | Poisson Exact CI 95% | Number at risk | Number of events | Incidence rate (per eye-year) | Poisson Exact CI 95% | |
| Cataract | 185 | 16 | 0.18 | 0.10–0.28 | 96 | 12 | 0.26 | 0.14–0.46 | 54 | 4 | 0.15 | 0.04–0.39 |
| Glaucoma/Ocular hypertension | 202 | 11 | 0.10 | 0.05–0.17 | 109 | 8 | 0.13 | 0.05–0.25 | 59 | 1 | 0.03 | 0.0004–0.16 |
| Epiretinal membrane | 200 | 11 | 0.09 | 0.04–0.16 | 109 | 6 | 0.09 | 0.03–0.19 | 57 | 5 | 0.15 | 0.05–0.36 |
| Optic nerve atrophy | 204 | 9 | 0.07 | 0.03–0.14 | 110 | 5 | 0.07 | 0.02–0.16 | 59 | 3 | 0.09 | 0.02–0.26 |
| Rhegmatogenous retinal detachment | 201 | 6 | 0.05 | 0.02–0.11 | 109 | 1 | 0.01 | 0.0001–0.07 | 59 | 3 | 0.09 | 0.02–0.27 |
| Cystoid macular edema | 191 | 0 | 0 | NA | 104 | 0 | 0 | NA | 54 | 0 | 0 | NA |
| Choroidal neovascularization | 200 | 0 | 0 | NA | 108 | 0 | 0 | NA | 58 | 0 | 0 | NA |
| Occlusion of major retinal vessel | 202 | 0 | 0 | NA | 109 | 0 | 0 | NA | 59 | 0 | 0 | NA |
| Visual acuity | ||||||||||||
| ≤20/50 | 69 | 4 | 0.10 | 0.03–0.25 | 37 | 2 | 0.08 | 0.009–0.30 | 21 | 2 | 0.20 | 0.02–0.71 |
| ≤20/200 | 126 | 5 | 0.06 | 0.02–0.14 | 74 | 3 | 0.06 | 0.001–0.18 | 35 | 2 | 0.10 | 0.01–0.35 |
Abbreviation: NA = not applicable. aThe format used in this table follows the format employed by Moradi et al.11.